AbbVie (ABBV) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for AbbVie (ABBV) over the last 10 years. The current PE ratio for AbbVie as of February 16, 2018 is 21.22.
|Medical||Large Cap Pharmaceutical||$188.334B||$28.216B|
|AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.|